Duvakitug outperformed placebo at week 14 in endoscopic response and was well tolerated among patients with moderately to severely active Crohn’s disease, according to research presented at ACG Annual ...
The support is broad to encourage institutions to consider how to address AI-related challenges and opportunities in ways ...
Eli Lilly & Company (NYSE:LLY) ranks among the stocks with the best earnings growth for the next 5 years. Cantor Fitzgerald ...
Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production ...
Manifold will use its tissue-targeting shuttle technology to help Roche develop new therapeutics for diseases of the central ...
In today’s ACT Brief, we explore how Eli Lilly’s orforglipron could become the first oral GLP-1 therapy reviewed under FDA’s new national priority program, and examine emerging regulatory and ethical ...
The healthcare industry has proven to be a resilient place for investors to put cash to work over the years. If you are ...
Or how about the drug companies? Holy cow, remember them? They used to be big and important, weren’t they? Eli Lilly reported ...
Discover how the Magnificent 7 stocks and artificial intelligence demand fueled a record S&P 500 earnings surge in Q3 2025, driving market optimism and sector leadership.
The AI chip darling already has the most cutting-edge products and the best customers. The next thing to do is to find more of them.
The rise of artificial intelligence is not only affecting how people work—it’s also shaping the job market itself, especially ...
GPU semiconductor factory, Jensen Huang’s roadmap connects data centers, networks, and industrial systems into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results